{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:22:45Z","timestamp":1792689765484,"version":"4.5.0"},"reference-count":45,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"4","license":[{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2019,3,22]]},"DOI":"10.1167\/iovs.18-24935","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T16:30:32Z","timestamp":1553272232000},"page":"1076","source":"Crossref","is-referenced-by-count":13,"title":["A New Ophthalmic Pharmaceutical Formulation, Topical Sulglycotide, Enhances the Ocular Mucin Secretion in Desiccation Stress-Mediated Dry Eye Disease"],"prefix":"10.1167","volume":"60","author":[{"given":"Hyesook","family":"Lee","sequence":"first","affiliation":[{"name":"T2B Infrastructure Center for Ocular Diseases, Inje University Busan Paik Hospital, Busanjin-gu, Busan, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangwon","family":"Jeon","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Ajou University, Yeongtong-gu, Suwon City, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae Eun","family":"Kim","sequence":"additional","affiliation":[{"name":"T2B Infrastructure Center for Ocular Diseases, Inje University Busan Paik Hospital, Busanjin-gu, Busan, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Joon","family":"Park","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Ajou University, Yeongtong-gu, Suwon City, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewook","family":"Yang","sequence":"additional","affiliation":[{"name":"T2B Infrastructure Center for Ocular Diseases, Inje University Busan Paik Hospital, Busanjin-gu, Busan, Republic of Korea"},{"name":"Department of Ophthalmology, Inje University College of Medicine, Busanjin-gu, Busan, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-60-4-1076-b01","unstructured":"Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report (2017). Ocul Surf. 2017; 15: 276\u2013283."},{"key":"i1552-5783-60-4-1076-b02","doi-asserted-by":"crossref","unstructured":"Rhee MK, Mah FS. Inflammation in dry eye disease; how do we break the cycle? Am J Ophthalmol. 2017; 124: S14\u2013S19.","DOI":"10.1016\/j.ophtha.2017.08.029"},{"key":"i1552-5783-60-4-1076-b03","doi-asserted-by":"crossref","unstructured":"Pflugfelder SC, Stern ME. Mucosal environmental sensors in the pathogenesis of dry eye. Expert Rev Clin Immunol. 2014; 10: 1137\u20131140.","DOI":"10.1586\/1744666X.2014.944163"},{"key":"i1552-5783-60-4-1076-b04","doi-asserted-by":"crossref","unstructured":"Willcox MDP, Arg\u00fceso P, Georgiev GA, et al. TFOS DEWS II tear film report. Ocul Surf. 2017; 15: 366\u2013403.","DOI":"10.1016\/j.jtos.2017.03.006"},{"key":"i1552-5783-60-4-1076-b05","doi-asserted-by":"crossref","unstructured":"Peng CC, Cerretani C, Li Y, Bowers S, et al. Flow evaporimeter to assess evaporative resistance of human tear-film lipid layer. Ind Eng Chem Res. 2014; 53: 18130\u201318131.","DOI":"10.1021\/ie5030497"},{"key":"i1552-5783-60-4-1076-b06","unstructured":"Wolff E. The muco-cutaneous junction of the lid margin and the distribution of the tear fluid. Trans Ophthalmol Soc UK. 1946; 66: 291\u2013308."},{"key":"i1552-5783-60-4-1076-b07","doi-asserted-by":"crossref","unstructured":"Holly FJ, Lemp MA. Tear physiology and dry eyes. Surv Ophthalmol. 1977; 22: 69\u201387.","DOI":"10.1016\/0039-6257(77)90087-X"},{"key":"i1552-5783-60-4-1076-b08","doi-asserted-by":"crossref","unstructured":"Gipson IK, Hori Y, Argueso P. Character of ocular surface mucins and their alteration in dry eye disease. Ocul Surf. 2004; 2: 131\u2013148.","DOI":"10.1016\/S1542-0124(12)70149-0"},{"key":"i1552-5783-60-4-1076-b09","unstructured":"Danjo Y, Watanabe H, Tisdale AS, et al. Alteration of mucin in human conjunctival epithelia in dry eye. Invest Ophthalmol Vis Sci. 1998; 39: 2602\u20132609."},{"key":"i1552-5783-60-4-1076-b10","doi-asserted-by":"crossref","unstructured":"Hodges RR, Dartt DA. Tear film mucins: front line defenders of the ocular surface: comparison with airway and gastrointestinal tract mucins. Exp Eye Res. 2013; 117: 62\u201378.","DOI":"10.1016\/j.exer.2013.07.027"},{"key":"i1552-5783-60-4-1076-b11","doi-asserted-by":"crossref","unstructured":"Stephens DN, McNamara NA. Altered mucin and glycoprotein expression in dry eye disease. Optom Vis Sci. 2015; 92: 931\u2013938.","DOI":"10.1097\/OPX.0000000000000664"},{"key":"i1552-5783-60-4-1076-b12","doi-asserted-by":"crossref","unstructured":"Nagahara Y, Koh S, Nishida K, et al. Prolonged increase in tear meniscus height by 3% diquafosol ophthalmic solution in eyes with contact lenses. Clin Ophthalmol. 2015; 9: 1029\u20131031.","DOI":"10.2147\/OPTH.S86173"},{"key":"i1552-5783-60-4-1076-b13","doi-asserted-by":"crossref","unstructured":"Bremond-Gignac D, Gicquel JJ, Chiambaretta F. Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sj\u00f6gren's syndrome. Exp Opin Drug Metab Toxicol. 2014; 10: 905\u2013913.","DOI":"10.1517\/17425255.2014.915026"},{"key":"i1552-5783-60-4-1076-b14","unstructured":"Fujihara T, Murakami T, Fujita H, et al. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model. Invest Ophthalmol Vis Sci. 2001; 42: 96\u2013100."},{"key":"i1552-5783-60-4-1076-b15","doi-asserted-by":"crossref","unstructured":"Fujihara T, Murakami T, Nagano T, et al. INS365 suppresses loss of corneal epithelial integrity by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model. J Ocul Pharmacol Ther. 2002; 18: 363\u2013370.","DOI":"10.1089\/10807680260218524"},{"key":"i1552-5783-60-4-1076-b16","unstructured":"Takaoka-Shichijo Y, Murakami T, Nakamura M. Stimulatory effect of diquafosol tetrasodium on tear fluid secretion in normal rabbits [in Japanese]. Atarashii Ganka. 2011; 28: 1029\u20131033."},{"key":"i1552-5783-60-4-1076-b17","unstructured":"Lau OC, Samarawickrama C, Skalicky SE. P2Y2 receptor agonists for the treatment of dry eye disease: a review. Clin Ophthalmol. 2014; 8: 327\u2013334."},{"key":"i1552-5783-60-4-1076-b18","doi-asserted-by":"crossref","unstructured":"Koh S. Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes. Clin Ophthalmol. 2015; 15: 865\u2013872.","DOI":"10.2147\/OPTH.S69486"},{"key":"i1552-5783-60-4-1076-b19","doi-asserted-by":"crossref","unstructured":"Kinoshita S, Awamura S, Oshiden K, et al. Rebamipide Ophthalmic Suspension Phase II Study Group Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study. Ophthalmology. 2012; 119: 2471\u20132478.","DOI":"10.1016\/j.ophtha.2012.06.052"},{"key":"i1552-5783-60-4-1076-b20","doi-asserted-by":"crossref","unstructured":"Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med Biol. 2002; 506: 989\u2013998.","DOI":"10.1007\/978-1-4615-0717-8_140"},{"key":"i1552-5783-60-4-1076-b21","doi-asserted-by":"crossref","unstructured":"Slomiany BL, Piotrowski J, Slomiany A. Gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide: down-regulation of nitric oxide synthase-2 and caspase-3 by sulglycotide. Biochem Biophys Res Commun. 1999; 261: 15\u201320.","DOI":"10.1006\/bbrc.1999.1003"},{"key":"i1552-5783-60-4-1076-b22","doi-asserted-by":"crossref","unstructured":"Chasseaud LF, Fry BJ, Saggers VH, et al. Studies on the possible absorption of a sulphated glycopeptide (GLPS) in relation to its mode of action. Biochem Pharm. 1972; 21: 3121\u20133130.","DOI":"10.1016\/0006-2952(72)90139-6"},{"key":"i1552-5783-60-4-1076-b23","unstructured":"Bertellini G, Butti A, Piantanida B, et al. Studies on glycoproteins of animal origin and on their derivatives. I and II. Arzneimittelforschung. 1971; 21: 244\u2013247."},{"key":"i1552-5783-60-4-1076-b24","doi-asserted-by":"crossref","unstructured":"Robert A, Nezamis JE, Lancaster C, et al. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology. 1979; 77: 433\u2013443.","DOI":"10.1016\/0016-5085(79)90002-7"},{"key":"i1552-5783-60-4-1076-b25","doi-asserted-by":"crossref","unstructured":"Lee HS, Shim WS, Kim CE, et al. Therapeutic efficacy of nanocomplex of poly(ethylene glycol) and catechin for dry eye disease in a mouse model. Invest Ophthalmol Vis Sci. 2017; 58: 1682\u20131691.","DOI":"10.1167\/iovs.16-20843"},{"key":"i1552-5783-60-4-1076-b26","doi-asserted-by":"crossref","unstructured":"Lee HS, Kim CE, Ahn BN, et al. Anti-inflammatory effect of hydroxyproline-GQDGLAGPK in desiccation stress-induced experimental dry eye mouse model. Sci Rep. 2017; 7: 7413.","DOI":"10.1038\/s41598-017-07965-4"},{"key":"i1552-5783-60-4-1076-b27","doi-asserted-by":"crossref","unstructured":"Villareal AL, Farley W, Pflugfelder SC. Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice. Eye Contact Lens. 2006; 32: 272\u2013276.","DOI":"10.1097\/01.icl.0000224360.10319.b1"},{"key":"i1552-5783-60-4-1076-b28","doi-asserted-by":"crossref","unstructured":"De Paiva CS, Corrales RM, Villarreal AL, et al. Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest Ophthalmol Vis Sci. 2006; 47: 2847\u20132856.","DOI":"10.1167\/iovs.05-1281"},{"key":"i1552-5783-60-4-1076-b29","unstructured":"Lemp MA. Report of the National Eye Institute\/Industry workshop on clinical trials in dry eyes. CLAO J. 1995; 21: 221\u2013232."},{"key":"i1552-5783-60-4-1076-b30","doi-asserted-by":"crossref","unstructured":"Pflugfelder SC, Farley W, Luo L, et al. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol. 2005; 166: 61\u201371.","DOI":"10.1016\/S0002-9440(10)62232-8"},{"key":"i1552-5783-60-4-1076-b31","unstructured":"Kim CE, Oh HN, Lee JH, et al. Effects of chondrocyte-derived extracellular matrix in a dry eye mouse model. Mol Vis. 2015; 21: 1210\u20131223."},{"key":"i1552-5783-60-4-1076-b32","doi-asserted-by":"crossref","unstructured":"Luo L, Li DQ, Doshi A, et al. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci. 2004; 45: 4293\u20134301.","DOI":"10.1167\/iovs.03-1145"},{"key":"i1552-5783-60-4-1076-b33","doi-asserted-by":"crossref","unstructured":"Nebbioso M, Del Regno P, Gharbiya M, et al. Analysis of the pathogenic factors and management of dry eye in ocular surface disorders. Int J Mol Sci. 2017; 18: 1764.","DOI":"10.3390\/ijms18081764"},{"key":"i1552-5783-60-4-1076-b34","doi-asserted-by":"crossref","unstructured":"Feng Y, Feng G, Peng S, et al. The effect of hormone replacement therapy on dry eye syndrome evaluated with schirmer test and break-up time. J Ophthalmol. 2015; 2015: 420302.","DOI":"10.1155\/2015\/420302"},{"key":"i1552-5783-60-4-1076-b35","doi-asserted-by":"crossref","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017; 15: 438\u2013510.","DOI":"10.1016\/j.jtos.2017.05.011"},{"key":"i1552-5783-60-4-1076-b36","doi-asserted-by":"crossref","unstructured":"Yokoi N, Bron AJ, Georgiev GA. The precorneal tear film as a fluid shell: the effect of blinking and saccades on tear film distribution and dynamics. Ocul Surf. 2014; 12: 252\u2013266.","DOI":"10.1016\/j.jtos.2014.01.006"},{"key":"i1552-5783-60-4-1076-b37","doi-asserted-by":"crossref","unstructured":"Gipson IK, Argueso P. Role of mucins in the function of the corneal and conjunctival epithelia. Int Rev Cytol. 2003; 231: 1\u201349.","DOI":"10.1016\/S0074-7696(03)31001-0"},{"key":"i1552-5783-60-4-1076-b38","unstructured":"Inatomi T, Spurr-Michaud S, Tisdale AS, et al. Expression of secretory mucin genes by human conjunctival epithelia. Invest Ophthalmol Vis Sci. 1996; 37: 1684\u20131692."},{"key":"i1552-5783-60-4-1076-b39","doi-asserted-by":"crossref","unstructured":"Spurr-Michaud S, Argueso P, Gipson I. Assay of mucins in human tear fluid. Exp Eye Res. 2007; 84: 939\u2013950.","DOI":"10.1016\/j.exer.2007.01.018"},{"key":"i1552-5783-60-4-1076-b40","doi-asserted-by":"crossref","unstructured":"Govindarajan B, Gipson IK. Membrane-tethered mucins have multiple functions on the ocular surface. Exp Eye Res. 2010; 90: 655\u2013663.","DOI":"10.1016\/j.exer.2010.02.014"},{"key":"i1552-5783-60-4-1076-b41","doi-asserted-by":"crossref","unstructured":"Gipson IK, Spurr-Michaud S, Tisdale A, et al. Comparison of the transmembrane mucins MUC1 and MUC16 in epithelial barrier function. PLoS One. 2014; 9: e100393.","DOI":"10.1371\/journal.pone.0100393"},{"key":"i1552-5783-60-4-1076-b42","doi-asserted-by":"crossref","unstructured":"Gipson IK, Spurr-Michaud SJ, Senchyna M, et al. Comparison of mucin levels at the ocular surface of postmenopausal women with and without a history of dry eye. Cornea. 2011; 30: 1346\u20131352.","DOI":"10.1097\/ICO.0b013e31820d852a"},{"key":"i1552-5783-60-4-1076-b43","unstructured":"Arg\u00fceso P, Balaram M, Spurr-Michaud S, et al. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome. Invest Ophthalmol Vis Sci. 2002; 43: 1004\u20131011."},{"key":"i1552-5783-60-4-1076-b44","doi-asserted-by":"crossref","unstructured":"Pflugfelder SC, de Paiva CS, Villarreal AL, et al. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production. Cornea. 2008; 27: 64\u201369.","DOI":"10.1097\/ICO.0b013e318158f6dc"},{"key":"i1552-5783-60-4-1076-b45","doi-asserted-by":"crossref","unstructured":"Wieczorek R, Jakobiec FA, Sacks EH, et al. The immunoarchitecture of the normal human lacrimal gland. Relevancy for understanding pathologic conditions. Ophthalmology. 1988; 95: 100\u2013109.","DOI":"10.1016\/S0161-6420(88)33228-8"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2729030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:02Z","timestamp":1791927062000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-24935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,22]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-24935","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,22]]}}}